Osteogenesis imperfecta: pathophysiology and treatment

Area of Science:

• Genetics
• Orthopedics
• Pediatrics

Background:

• Osteogenesis imperfecta (OI) is a rare inherited disorder primarily affecting collagen, crucial for bone structure.
• Mutations can impair collagen synthesis, leading to weakened bones and increased fracture risk.
• Recessive forms of OI impact osteoblast and osteoclast function, influencing bone remodeling.

Purpose of the Study:

• To summarize the key features, genetic basis, and current management strategies for Osteogenesis Imperfecta.
• To highlight the clinical manifestations and therapeutic interventions for patients with OI.

Main Methods:

• Review of existing literature on Osteogenesis Imperfecta.
• Analysis of clinical signs, genetic causes, and treatment protocols.

Main Results:

• OI presents with frequent fractures, bone deformities, and potential complications like dwarfism, scoliosis, dentinogenesis imperfecta, deafness, and blue sclera.
• Intravenous bisphosphonates are standard in childhood to enhance bone mass and reduce fractures.
• Surgical interventions are necessary for fracture repair and deformity correction, complemented by physical therapy.

Conclusions:

• Osteogenesis Imperfecta requires a multidisciplinary approach involving medical, surgical, and rehabilitative care.
• Early diagnosis and management are crucial for improving outcomes and quality of life in affected individuals.